Status:
COMPLETED
Evaluation of Adding Lidocaine to Dexamethasone in Intra-tympanic Injection for Management of Tinnitus
Lead Sponsor:
saad elzayat
Conditions:
Tinnitus
Eligibility:
All Genders
30-63 years
Phase:
PHASE1
Brief Summary
Importance; Tinnitus is a heterogeneous diagnosis that may occur alone, in the presence of hearing loss or as a component of other disorders and can be quite disabling. Intratympanic injections of med...
Detailed Description
Introduction Tinnitus is a heterogeneous diagnosis that may occur alone, in the presence of hearing loss, or as a component of other disorders and can be quite disabling. Tinnitus has been estimated t...
Eligibility Criteria
Inclusion
- Idiopathic subjective non-pulsatile tinnitus (IST)
Exclusion
- Extreme age, pulsatile tinnitus, objective tinnitus and ear inflammation.
Key Trial Info
Start Date :
March 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT03265197
Start Date
March 1 2015
End Date
April 1 2016
Last Update
August 29 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.